An Open-label, Single-dose Study to Evaluate the Pharmacokinetic Profiles of 14 mg Teriflunomide Tablet in Healthy Chinese Subjects
Phase of Trial: Phase I
Latest Information Update: 25 Aug 2014
Price : $35 *
At a glance
- Drugs Teriflunomide (Primary) ; Colestyramine
- Indications Multiple sclerosis
- Focus Pharmacokinetics
- Sponsors Sanofi
- 20 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 21 Jul 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 17 Jul 2014 Planned End Date changed from 1 Jul 2014 to 1 Aug 2014 as reported by ClinicalTrials.gov record.